Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06272435 · ClinicalTrials.gov registry record · NA
Beverage Hydration Index: Assessment of Four Rehydration Solutions
A NA study, sponsored by University of Memphis.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT06272435: Completed NA study, sponsored by University of Memphis.
NCT06272435 is a NA study that has completed, run by University of Memphis. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06272435, a NA study, has completed, sponsored by University of Memphis.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
No studies to date to evaluate the effects of the three different liquid IV electrolyte products on the beverage hydration index (BHI). Therefore, the purpose of this study is to determine the impact of three different LIV products (Hydration multiplier, Sugar Free formulation with Amino Acids, and Sugar Free with allulose) on hydration status in young and active men and women compared to a control (water). The study will follow the same approach as used by Maughan and colleagues (2016) to measure the fluid balance (the difference between the amount of water consumed and passed as urine) and BHI (the relative amount of urine passed after consumption of a drink compared to water) including time in positive fluid balance, as well as determining electrolyte concentrations, osmolality, specific gravity, and sodium and potassium in urine.
Primary Outcome
Beverage Hydration index calculated as mass of urine collected following control (water) consumption divided by the mass of urine collected following treatment.
Interventions
- DIETARY_SUPPLEMENT Water
- DIETARY_SUPPLEMENT Multiplier
- DIETARY_SUPPLEMENT Sugar Free
- DIETARY_SUPPLEMENT Sugar Free with Amino Acids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2023-12-23 |
| Est. Completion | 2024-09-06 |
| Phase | NA |
What the finished NCT06272435 record still lists
NCT06272435 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which Water is the first listed.
NCT06272435 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06272435 about?
NCT06272435 is a clinical study titled "Beverage Hydration Index: Assessment of Four Rehydration Solutions". No studies to date to evaluate the effects of the three different liquid IV electrolyte products on the beverage hydration index (BHI). Therefore, the purpose of this study is to determine the impact of three different LIV products (Hydration multiplier, Sugar Free formulation with Amino Acids, and ...
What is the current status of trial NCT06272435?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2023-12-23. Estimated completion is 2024-09-06.
What interventions are being tested in trial NCT06272435?
The interventions under investigation include: Water (DIETARY_SUPPLEMENT), Multiplier (DIETARY_SUPPLEMENT), Sugar Free (DIETARY_SUPPLEMENT), Sugar Free with Amino Acids (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06272435?
This trial is sponsored by University of Memphis, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06272435's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI